← Browse by Condition
Medical Condition

cognitive dysfunction

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 1, Phase 2, Phase 2

ClinicalMetric tracks all active clinical trials for cognitive dysfunction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cognitive dysfunction Clinical Trials

How many clinical trials are currently recruiting for cognitive dysfunction?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for cognitive dysfunction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognitive dysfunction?
cognitive dysfunction research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognitive dysfunction clinical trial?
Eligibility criteria for cognitive dysfunction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Top Sponsors
Foundation University Islamabad 2 trials
University of Ulster 1 trial
Dartmouth-Hitchcock Medical Center 1 trial
Nanfang Hospital, Southern Medical University 1 trial
Paul E Schulz 1 trial

Recruiting Clinical Trials

NCT07226674
Recruiting
Microbiota Mediated Flavonoid Metabolites for Cognitive Health
Enrollment
100 pts
Location
United Kingdom
Sponsor
University of Ulster
View Trial →
NCT07182396
Recruiting
Effects of Video Games and Ball Tossing on Eye Hand Coordination in Elderly With Mild Cognitive Impairment.
Enrollment
34 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →
NCT06951919
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce...
View Trial →
NCT06672367
Recruiting
Effects of Balance Training with and Without Gaze Stability Exercises on Cognitive Function Balance and Dynamic Postural Stability in Older Adults with Mild Cognitive Impairment
Enrollment
32 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →
NCT06817239
Recruiting
Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT)
Enrollment
1,670 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →
NCT06775964 Phase 1, Phase 2
Recruiting
Stem Cell Therapy for Early Alzheimer's Disease
Enrollment
12 pts
Location
United States
Sponsor
Paul E Schulz
View Trial →
NCT07517237
Recruiting
taVNS + CCT for Neurocognitive Rehab
Enrollment
20 pts
Location
United States
Sponsor
Medical University of South Ca...
View Trial →
NCT07589595 Phase 2
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Enrollment
350 pts
Location
United States, Japan...
Sponsor
Eli Lilly and Company
View Trial →
NCT03175302
Recruiting
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Enrollment
25,240 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05114876
Recruiting
Redesigning the Surgical Pathway (PROMoTE)
Enrollment
260 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →

Related Conditions

cognitive decline (3) cognitive disorder (1) multiple sclerosis (1) memory disorders (1) memory impairment (1) memory dysfunction (1) elderly population (1) delirium in old age (1) delirium postoperative (1) anesthesia (1) pain postoperative (1) esketamine (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology